About FDA
Number of product safety assessment meetings coordinated for public review in the month
Dictionary: Pediatric labeling changes for drug and biological products trigger mandated safety reviews for adverse events that may occur in children. Three pediatric advisory committee (PAC) meetings are held each year to hear these safety reviews, discuss the findings, and make recommendations to FDA. In 2010, pediatric safety reviews presented to the PAC have now been expanded to include blood products and vaccines. The safety reviews are the basis of the issues meetings which define much of the above PAC agenda.
Information is current as of December 31, 2012.
Fiscal Year - 2012
| Time | Target | Number of Reviews |
|---|---|---|
| Oct 2011 | N/A | 5 |
| Nov 2011 | N/A | 13 |
| Dec 2011 | N/A | 6 |
| Jan 2012 | N/A | 17 |
| Feb 2012 | N/A | 1 |
| Mar 2012 | N/A | 23 |
| Apr 2012 | N/A | 20 |
| May 2012 | N/A | 0 |
| Jun 2012 | N/A | 5 |
| Jul 2012 | N/A | 19 |
| Aug 2012 | N/A | 8 |
| Sep 2012 | N/A | 16 |
FY 2012 Total: 133
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
